Bone Morphogenetic Proteins
Future FDA action may likewise be specific rather than universal
10.1016/j.pharmthera.2007.07.006 7 Alescio-LautierB.PabanV.Soumireu-MouratB
Great value for professionals needing multi-dose solutions
Any clinician with athlete patients should verify current World Anti-Doping Agency (WADA) status before discussing DSIP, because the consequences of a positive test fall on the patient, not the practice
Exendin-4 and liraglutide reduced the expression of genes involved in cholesterol synthesis ( ACAT1 , SREBP-2 , HMGCR , and SQLE ), bile acid synthesis ( LXR and CYP7A1 ), and the PCSK9 gene, while increasing the expression of genes associated with the RCT pathway ( ABCA1 and SR-B1 ) and LDL-C uptake ( LDLR )